Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.435 USD | -0.79% | -5.79% | -4.36% |
05-13 | Recursion Pharmaceuticals Says BioHive-2 AI Supercomputer Completed | MT |
05-10 | Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.36% | 2.26B | |
+9.49% | 114B | |
+13.05% | 107B | |
-6.69% | 22.22B | |
-1.46% | 21.28B | |
-4.55% | 18.8B | |
-6.02% | 17.51B | |
-39.36% | 17.17B | |
+6.22% | 14.14B | |
+34.71% | 12.2B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- SVB Leerink Downgrades Recursion Pharmaceuticals to Market Perform from Outperform, Adjusts Price Target to $10 from $32